Navigation Links
Effects of Thermal Cycler Well-To-Well Temperature Uniformity on PCR Results


Better temperature uniformity allows for better control of PCR reactions

Michelle Cayouette Jane Moores Jason Capodanno Michael Rahilly
Stratagene

Stratagenes RoboCycler temperature cycler # produces consistent PCR results in every well. The RoboCycler systems unique design uses thermal blocks and heating techniques that are optimized for block temperature uniformity. In this study, fluid temperature profiles and PCR results were determined using both a RoboCycler 96 temperature cycler and a typical Peltier single-block thermal cycler, the MJ Research PTC-100. The RoboCycler system showed better fluid temperature well-to-well uniformity, faster fluid temperature ramping rates, and more consistent PCR-product banding patterns.

When performing PCR amplifications, reaction components and PCR parameters are not the only criteria that affect the quality of results; differences may also exist in the ability of thermal cyclers to maintain a consistent temperature both within and between experiments. If the well-to-well temperature across the thermal block is not uniform, it can have a significant impact on the PCR. This is an especially important consideration for researchers performing quantitative or diagnostic PCR assays using multiple samples.

The four-block design common to all members of Stratagenes RoboCycler line of thermal cyclers provides a higher degree of well-to-well uniformity than the single-block design of many other thermal cyclers. Each of the three RoboCycler hot blocks is heated using a microprocessor-controlled resistive element heater, which covers 95% of the bottom surface of each block. Other thermal cyclers, such as the MJ Research thermal cyclers, use Peltier thermal electric modules attached to the bottom of a single block for heating and cooling. However, the Peltier modul
'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Measuring Gene Silencing Effects by RT-PCR Without RNA Isolation
2. Confirming RNAi Effects Is Now Easier Than Ever
3. Thermal Cycling Profile for Standard PCR
4. New Temperature Cycler Features Interchangeable Blocks
5. The LightCycler is the only System for Quantitative PCR that is as Flexible as You are!
6. Screening of Beer-Spoilage Bacteria Using the LightCycler PCR Workflow System
7. LightCycler foodproof Beer Screening Kit
8. Quantification of siRNA Silencing Efficiency Using the LightCycler System
9. Gene-Expression Analysis of TP, DPD, and TS Using the LightCycler mRNA Quantification KitsPLUS
10. Real-Time Multiplex PCR from Genomic DNA Using the iCycler iQ Detection System
11. Identification of Nonspecific Products Using Melt-Curve Analysis on the iCycler iQ Detection System, Rev A

Post Your Comments:
(Date:11/6/2009)...Nov. 6 ,, 3Q09 Cor...Qutenza(TM) E.U. Marketing Authorization to Astell...in commercial readiness activities Expanded manag...arketing; and Director, Commercial Operations App...d Audit Committee chairman , Upcoming 2009 ...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personalize...o take place on February 22-24, 2010 in Philadelph...ce we will highlight key issues in forming partner...experiences. , Minneapoli...rrowhead’s 2010 Personalized Medicine Partn...
(Date:11/5/2009)...ov. 5 DSM Pharmaceutical Products ...lliance with Galenix, Saint Jean D,Illac, France, ...anufacturing partner for Galenix commercial produc...ollaborate on business development opportunities c...sed on the strength of Galenix in drug product dev...
(Date:11/5/2009)... Transgenomic, Inc. (OTC...esults for the quarter ended September 30, 2009. T...e tables that follow. ,, Third Quarter 2009 ,...r $0.01 per share for the third quarter of 2009 as...hare for the third quarter of 2008. ,, Net sal...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...on (Nasdaq: DNDN ) announced today the closing o...ring of 10,700,000 shares of its common stock, whi...19.20 per share. On May 8, 2009, Deutsche Bank Se...ing, exercised in full its over-allotment option t...n stock at the public offering price of $19.20 per...
...A has approved an,Investigational New Drug (IND) a... phase I clinical study with its selective PLK-1 s...r. PLK-1 is a mitotic kinase required for,the prol...ally bioavailable,highly efficient and well tolera... dosing. This unique inhibitor adds another promis...
...nc. (Xennex) announced today a major leap for Gene...ilable at http://www.genecards.org/v3 . , , ...ntly upgraded infrastructure, including a comprehe... sophisticated and speedier search engine. It prov...rgeted queries, a user-friendly display and clear ...
Other Biology Technology:Dendreon Announces Closing of Common Stock Offering 2Dendreon Announces Closing of Common Stock Offering 3Nerviano Medical Sciences Receives Approval From the FDA to Enter Phase I Clinical Trials for Their Polo Like Kinase (PLK) Inhibitor 2GeneCards(R) Version 3.0 Beta Released 2GeneCards(R) Version 3.0 Beta Released 3
(Date:11/4/2009)... 20 Quest Diagnostics In...ider of diagnostic testing, information and servic...tember 30, 2009, income from continuing operations... from $160 million, or $0.81 per diluted share, fo...r results were reduced by a $0.03 per share charge...
(Date:11/4/2009).... 20 Aware, Inc. (Nasdaq...ogy and biometrics software, today reported financ... 30, 2009. ,, Michael Tzannes, Aware,s Chairm...ay, we announced an agreement to sell our DSL and ...less semiconductor company being spun out of Infin...
(Date:11/4/2009)...ct. 23 GenVault Corporation, the l...for genomic discovery, medicine and identification...lt,s President and CEO, will be presenting at the ... 26th and 27th in La Jolla, CA. ,, During the p...f the company together with recent customer, techn...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 1Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 2Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 3Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 4GENova gains access to Big Pharma 57148 1GENova gains access to Big Pharma 57148 2GENova gains access to Big Pharma 57148 3Frost 26 Sullivan 3A First Responders Communication Interoperability A Vital Need for Life Saving Services 57146 1Frost 26 Sullivan 3A First Responders Communication Interoperability A Vital Need for Life Saving Services 57146 2
...f the words "parasitic worms," it,s a fact that so...At Michigan State University, researcher Linda Man...vestigating the role that parasites can play in tr...ns. , Her research is part of a more than $10 mil...g the Food and Waterborne Diseases Integrated Rese...
...enomes (IMG) data management system of the U.S. De...) has been released to the public. IMG 1.5 now con...chaeal, 15 eukaryotic genomes and 259 bacterial ph...genomes. , IMG 1.5 contains 62 finished and 100 ...total to 162 microbial genomes generated in-house....
...eloped a new low-cost system that analyzes scatter...plications in medicine, food processing and homela...technologies. , The technique - Bacteria Rapid De...s by shining a laser through a petri dish containi.... , "Unlike conventional methods, we don,t have ...
Other Biology News:Parasitic worms used to fight bowel disease 2DOE JGI releases IMG 1.5 with curated archaeal genomes 2Purdue creates new low-cost system to detect bacteria 2Purdue creates new low-cost system to detect bacteria 3Purdue creates new low-cost system to detect bacteria 4
MUTAN SUPER EXPRESS KM 20 RXN from Takara Mirus Bio
...omics Analyzer Mass Standards Kit includes reagent...timize instrument parameters, and calibrate the ma...s designed for use with the 4700 Proteomics Analyz...dards in the kit require minimal preparation and w...
Adaptor BamH I-Sma I from Takara Mirus Bio
Adaptor EcoR I Sma I from Takara Mirus Bio
Biology Products: